← TrialMatch
HomeTrials

Comparison Between a Mindfulness-Based Program and Standard Therapeutic Follow-Up During P

This study aims to evaluate the effects of a 6-week mindfulness meditation program in pregnant women, compared with a psychological support control program. Participants in the mindfulness arm will complete one instructor-led meditation session per week and five guided audio meditation sessions at home each week. The p

Condition(s)Mindfulness Protocols, Pregnancy
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThis study aims to evaluate the effects of a 6-week mindfulness meditation program in pregnant women, compared with a psychological support control program. Participants in the mindfulness arm will complete one instructor-led meditation session per week and five guided audio meditation sessions at home each week. The primary objectives are to determine whether the mindfulness program leads to: Reduced negative affect, including stress, anxiety, depression, and sleep disturbances during pregnancy. Increased positive affect, such as mindfulness skills, self-efficacy, happiness, and life satisfaction. Enhanced maternal-fetal attachment during pregnancy and improved maternal-infant attachment one month postpartum. Improved mother-infant interaction quality at 3 months postpartum. More secure i
Who can participateInclusion Criteria: * Pregnant women between 3 and 7.5 months of gestation (12-28 weeks). * Ability to speak and read French sufficient to understand study documents and complete questionnaires. * Willingness to participate in the study and to be randomized to one of the study groups. Exclusion Criteria: * Loss of the baby * Participation in other prenatal support programs, including prenatal yoga, haptonomy, sophrology, or mindfulness courses. * Severe or unstable psychiatric disorder. Inability to understand French or complete study questionnaires.
Ages18 Years to 45 Years
SexFemale
Accepts healthy volunteersYes
Lead sponsorUniversite Cote d'Azur
LocationsMouans-Sartoux, France
Start date2023-03-31
NCT IDNCT07364032
Official listinghttps://clinicaltrials.gov/study/NCT07364032

🔍 Search all trials →